Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05491551 · ClinicalTrials.gov registry record · NA
Alcohol-ROC-Training
A NA study of Heavy Drinking and Binge Drinking, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 177
- Enrollment target
- 2
- Study locations
NCT05491551: Recruiting NA study of Heavy Drinking and Binge Drinking, sponsored by Yale University.
NCT05491551 is a NA study of Heavy Drinking and Binge Drinking that is actively recruiting participants, run by Yale University. The registered enrollment target is 177 participants, below the 330-participant average among 9 other Heavy Drinking trials with a reported enrollment target (46% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05491551, a NA study of Heavy Drinking and Binge Drinking, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the proposed study is to examine whether brief training in regulation of craving (ROC-T) affects alcohol drinking. The study will consist of a basic screening (phone and online), and in person visit to determine eligibility and conduct pre-intervention baseline assessments, 1-4 training (ROC-T) visits, a post-intervention assessment visit, and 1-2 phone/online follow up assessments.The two active conditions of ROC-T are based on cognitive-behavioral treatments (CBT) and mindfulness-based treatments (MBT).
Primary Outcome
Self-reports of daily alcohol use via smartphone-based ecological momentary assessment (EMA) is the primary source for this outcome variable, with Timeline Follow-Back (TLFB) data inserted to replace missing data from EMA. A heavy drinking day is defined as more than 3 or 4 standard drinks per day for women/men.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Based Treatment-Regulation of Craving
- BEHAVIORAL Cognitive-Based Therapy-Regulation of Craving
Study Locations (2)
California
- University of California, Berkeley - Berkeley
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2022-09-28 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT05491551 shows while recruiting
NCT05491551 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 330-participant average among 9 other Heavy Drinking trials with a reported enrollment target (46% lower).
The record links to 4 conditions, with Heavy Drinking appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Based Treatment-Regulation of Craving is the first listed.
NCT05491551 reports a single indexed study location in California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05491551 about?
NCT05491551 is a clinical study titled "Alcohol-ROC-Training". The goal of the proposed study is to examine whether brief training in regulation of craving (ROC-T) affects alcohol drinking. The study will consist of a basic screening (phone and online), and in person visit to determine eligibility and conduct pre-intervention baseline assessments, 1-4 training ...
What is the current status of trial NCT05491551?
This trial is currently recruiting. It is a NA study. The enrollment target is 177 participants. The study started on 2022-09-28. Estimated completion is 2027-12.
What conditions does trial NCT05491551 study?
This clinical trial studies the following conditions: Heavy Drinking, Binge Drinking, Young Adult, Heavy Drinker.
What interventions are being tested in trial NCT05491551?
The interventions under investigation include: Mindfulness-Based Treatment-Regulation of Craving (BEHAVIORAL), Cognitive-Based Therapy-Regulation of Craving (BEHAVIORAL).
Who is sponsoring clinical trial NCT05491551?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05491551 being conducted?
This trial has 2 study locations across California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heavy Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05491551's enrollment target sits among peer trials
177 8th of 9 higher than 2 of 9 other Heavy Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heavy Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health
RECRUITING · NA
-
A Brief Intervention for Alcohol Users With Interpersonal Trauma
ACTIVE NOT RECRUITING · NA
-
Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care
ACTIVE NOT RECRUITING · NA
-
A Web Application to Reduce Heavy Drinking in First-time DWI Offenders
COMPLETED · NA
-
Brief Online Intervention for Veterans
COMPLETED · NA
-
Motivating Recruitment and Efficacy in Normative Feedback Interventions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
- NCT06719011 · 177 participants · Phase 1
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI